Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Fairness in Respondent Selection Act of 2015
Client: CATALYST PAPER · Firm: SIDLEY AUSTIN LLP
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Fairness in Respondent Selection Act of 2015
Client: CATALYST PAPER · Firm: SIDLEY AUSTIN LLP
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COPART, INC. via SIDLEY AUSTIN LLP
2017 · fourth_quarter · 4A
Disaster relief
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · fourth_quarter · 4A
Source: Senate LDA
| ARAMARK |
| 7 |
| 2007–2008 |
| CATALYST PAPER | 6 | 2015–2016 |
| SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION | 6 | 2009–2010 |
| ELI LILLY AND COMPANY | 5 | 2009–2010 |
| COPART, INC. | 4 | 2017 |
| MEDIMMUNE, LLC. | 4 | 2011–2013 |
| ST. JUDE MEDICAL, INC. | 3 | 2010 |
| NATIONAL STONE, SAND & GRAVEL ASSOCIATION | 2 | 2008 |
| ASSISTIVE TECHNOLOGY GROUP | 1 | 2009 |
| SOCIETY FOR DIAGNOSTIC MEDICAL SONOGRAPHY | 1 | 2007 |
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Fairness in Respondent Selection Act of 2015
Client: CATALYST PAPER · Firm: SIDLEY AUSTIN LLP
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Fairness in Respondent Selection Act of 2015
Client: CATALYST PAPER · Firm: SIDLEY AUSTIN LLP
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Fairness in Respondent Selection Act of 2015
Client: CATALYST PAPER · Firm: SIDLEY AUSTIN LLP
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Integrated Electronic Health Records (iEHR) for Military and Veterans Act
Client: MEDIMMUNE LLC · Firm: SIDLEY AUSTIN LLP
HR 2055 - Provisions relating to health and human services funding, Center for Disease Control and Prevention, burden of disease study on repiratory syncytial virus
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverageof A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Service Act
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act)
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Service Act
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act)
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: SOCIETY FOR DIAGNOSTIC MEDICAL SONOGRAPHY · Firm: SIDLEY AUSTIN LLP
Issues relating to the credentialing of sonographers; H.R. 583 and S. 1042 (the CARE Act); Medicare and Medicaid payment policy
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
Client: SOCIETY FOR DIAGNOSTIC MEDICAL SONOGRAPHY · Firm: SIDLEY AUSTIN LLP
Issues relating to the credentialing of sonographers; H.R. 583 and S. 1042 (the CARE Act); Medicare and Medicaid payment policy
Medicare
Filing targets: SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2017 · fourth_quarter · 4A
Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Medicare
Filing targets: SENATE
COPART, INC. via SIDLEY AUSTIN LLP
2017 · fourth_quarter · Q4
Disaster relief
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COPART, INC. via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Disaster relief
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · third_quarter · Q3
Medicare
Filing targets: SENATE
COPART, INC. via SIDLEY AUSTIN LLP
2017 · third_quarter · RR
Disaster Relief
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Medicare
Filing targets: SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2017 · second_quarter · Q2
Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2017 · first_quarter · Q1
Medicare
Filing targets: SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · fourth_quarter · Q4
Medicare
Filing targets: SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · third_quarter · Q3
Medicare
Filing targets: SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Medicare
Filing targets: SENATE
SHIRE PHARMACEUTICALS LLC via SIDLEY AUSTIN LLP
2016 · second_quarter · RR
Medicare
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CATALYST PAPER via SIDLEY AUSTIN LLP
2016 · second_quarter · Q2
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2016 · first_quarter · Q1
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CATALYST PAPER via SIDLEY AUSTIN LLP
2016 · first_quarter · Q1
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2015 · fourth_quarter · Q4
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CATALYST PAPER via SIDLEY AUSTIN LLP
2015 · fourth_quarter · Q4
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2015 · third_quarter · Q3
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CATALYST PAPER via SIDLEY AUSTIN LLP
2015 · third_quarter · Q3
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2015 · second_quarter · Q2
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2015 · second_quarter · Q2
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CATALYST PAPER via SIDLEY AUSTIN LLP
2015 · second_quarter · Q2
Department of Commerce/Trade remedies issues process including S.1702 and H.R.2945 (Fairness in Respondent Selection Act of 2015)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CATALYST PAPER via SIDLEY AUSTIN LLP
2015 · second_quarter · RR
Department of Commerce/Trade remedies issues process
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2015 · first_quarter · Q1
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2015 · first_quarter · Q1
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2015 · first_quarter · Q1
Access to perscription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2014 · fourth_quarter · Q4
Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2014 · fourth_quarter · Q4
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2014 · fourth_quarter · Q4
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2014 · third_quarter · Q3
Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2014 · third_quarter · Q3
Patient access to abuse deterrent pain relief drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2014 · third_quarter · Q3
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2014 · second_quarter · Q2
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2014 · second_quarter · Q2
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2014 · first_quarter · Q1
Issue relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2014 · first_quarter · Q1
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2013 · fourth_quarter · Q4
Issue relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2013 · fourth_quarter · Q4
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2013 · third_quarter · Q3
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2013 · third_quarter · Q3
Patient access to abuse-deterent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2013 · third_quarter · Q3
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2013 · second_quarter · Q2
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2013 · second_quarter · Q2
Patient access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2013 · second_quarter · Q2
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE LLC via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
HR 2055 - Provisions relating to health and human services funding, Center for Disease Control and Prevention, burden of disease study on repiratory syncytial virus
Filing targets: Health & Human Services, Dept of (HHS)
GRIFOLS INC via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act, and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
340B Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2012 · fourth_quarter · 4A
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act, and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2012 · fourth_quarter · 4A
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
Issues relating to regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
340B Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act, and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
Health care reform and implementation; policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
Issues relating to the regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
340B Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2012 · second_quarter · 2A
Health care reform and implementation; and policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · second_quarter · Q2
340B Issues
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2012 · second_quarter · Q2
Issues relating to the regulation of natural products, including food, nutritional supplements and natural cosmetics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · second_quarter · Q2
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATURAL PRODUCTS ASSOCIATION via SIDLEY AUSTIN LLP
2012 · second_quarter · RR
Issues relating to the regulation of natural products, including food, nutritional supplements and natural cosmetics
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Health care reform and implementation; and policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE LLC via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
HR 2055 - Provisions relating to health and human services funding, Center for Disease Control and Prevention, burden of disease study on respiratory syncytial virus
Filing targets: Health & Human Services, Dept of (HHS)
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
340B Issues
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · third_quarter · 3A
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2011 · fourth_quarter · Q4
Health care reform and implementation; and policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE LLC via SIDLEY AUSTIN LLP
2011 · fourth_quarter · Q4
HR 2055 - Provisions relating to health and human services funding, Center for Disease Control and Prevention, burden of disease study on respiratory syncytial virus
Filing targets: Health & Human Services, Dept of (HHS)
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · fourth_quarter · Q4
340B Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
MEDIMMUNE LLC via SIDLEY AUSTIN LLP
2011 · fourth_quarter · RR
HR 2055 - Provisions relating to health and human services funding, Center for Disease Control and Prevention, burden of disease study on respiratory syncytial virus
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · third_quarter · Q3
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2011 · third_quarter · Q3
Health care reform and implementation; and policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2011 · third_quarter · Q3
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · second_quarter · 2A
Coverageof A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2011 · second_quarter · Q2
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2011 · second_quarter · Q2
Health care reform and implementation; and policy issues relating to Medicare and Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2011 · first_quarter · Q1
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2011 · first_quarter · Q1
Health care reform and implementation; Medicare reimbursement issues; mental health issues; and policy issues relating to FDA/CMS parallel review
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · first_quarter · Q1
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2010 · fourth_quarter · 4A
Health care reform and implementation; Medicare reimbursement issues; mental health issues; and policy issues relating to FDA/CMS parallel review
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2010 · fourth_quarter · Q4
Medicaid Federal Upper Limit on drug reimbursement concerns
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2010 · fourth_quarter · Q4
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2010 · fourth_quarter · Q4
Health care reform and implementation; Medicare reimbursement issues; mental health issues; and policy issues relating to FDA/CMS parallel review
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2010 · fourth_quarter · Q4
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ST. JUDE MEDICAL, INC. via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Issues relating to 510K clearance for medical devices regulated under the Federal Food, Drug and Cosmetic Act
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Medicaid Federal Upper Limit on drug reimbursement concerns
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE